SCHEMBL7403447

SCHEMBL7403447

Nc1cccc(OCCN2CCC(Cc3ccccc3)CC2)c1N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 2/20 0.64
SIGMAR1 Q99720 2/20 0.64
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
KDM4E B2RXH2 4/20 0.61
ALDH1A1 P00352 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
DRD4 P21917 1/20 0.61
PRMT3 O60678 1/20 0.56
CARM1 Q86X55 1/20 0.56
PRMT6 Q96LA8 1/20 0.56
PRMT1 Q99873 1/20 0.56
PRMT8 Q9NR22 1/20 0.56
HTR1A P08908 1/20 0.54
HTR1D P28221 1/20 0.54
HTR1B P28222 1/20 0.54
CCR3 P51677 1/20 0.53
HRH3 Q9Y5N1 1/20 0.52
SLC6A2 P23975 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398178 0.91 TMEM97 (0.69) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL7402428 0.90 KDM4E (0.55) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL6208540 0.85 DRD4 (0.70) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL7401250 0.83 KMT2A (0.63) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL7404359 0.82 KDM4E (0.60) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL7399889 0.81 TMEM97 (0.69) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL7402687 0.81 KDM4E (0.72) TMEM97SIGMAR1MEN1KMT2AKDM4E
Hydrochloric Acid SCHEMBL7403750 0.80 TMEM97 (0.67) TMEM97SIGMAR1MEN1KMT2AKDM4E
Hydrochloric Acid SCHEMBL7407391 0.80 TMEM97 (0.67) TMEM97SIGMAR1MEN1KMT2AKDM4E
SCHEMBL5888854 0.79 TMEM97 (1.00) TMEM97SIGMAR1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed